1. Home
  2. SCLX vs CPSH Comparison

SCLX vs CPSH Comparison

Compare SCLX & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • CPSH
  • Stock Information
  • Founded
  • SCLX 2011
  • CPSH 1984
  • Country
  • SCLX United States
  • CPSH United States
  • Employees
  • SCLX N/A
  • CPSH N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • CPSH Building Materials
  • Sector
  • SCLX Health Care
  • CPSH Consumer Discretionary
  • Exchange
  • SCLX Nasdaq
  • CPSH Nasdaq
  • Market Cap
  • SCLX 35.7M
  • CPSH 36.6M
  • IPO Year
  • SCLX N/A
  • CPSH 1987
  • Fundamental
  • Price
  • SCLX $18.87
  • CPSH $3.14
  • Analyst Decision
  • SCLX Strong Buy
  • CPSH
  • Analyst Count
  • SCLX 3
  • CPSH 0
  • Target Price
  • SCLX $367.50
  • CPSH N/A
  • AVG Volume (30 Days)
  • SCLX 324.6K
  • CPSH 115.5K
  • Earning Date
  • SCLX 08-13-2025
  • CPSH 07-30-2025
  • Dividend Yield
  • SCLX N/A
  • CPSH N/A
  • EPS Growth
  • SCLX N/A
  • CPSH N/A
  • EPS
  • SCLX N/A
  • CPSH N/A
  • Revenue
  • SCLX $44,236,000.00
  • CPSH $25,764,977.00
  • Revenue This Year
  • SCLX $89.26
  • CPSH N/A
  • Revenue Next Year
  • SCLX $203.95
  • CPSH N/A
  • P/E Ratio
  • SCLX N/A
  • CPSH N/A
  • Revenue Growth
  • SCLX N/A
  • CPSH 7.46
  • 52 Week Low
  • SCLX $3.60
  • CPSH $1.29
  • 52 Week High
  • SCLX $45.15
  • CPSH $3.58
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 63.34
  • CPSH 55.85
  • Support Level
  • SCLX $15.61
  • CPSH $2.87
  • Resistance Level
  • SCLX $22.01
  • CPSH $3.37
  • Average True Range (ATR)
  • SCLX 2.21
  • CPSH 0.27
  • MACD
  • SCLX -0.14
  • CPSH -0.00
  • Stochastic Oscillator
  • SCLX 62.35
  • CPSH 51.65

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About CPSH CPS Technologies Corp.

CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.

Share on Social Networks: